These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29178334)

  • 21. Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model.
    Shibao S; Minami N; Koike N; Fukui N; Yoshida K; Saya H; Sampetrean O
    Neuro Oncol; 2018 Feb; 20(3):343-354. PubMed ID: 29016888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines.
    Griguer CE; Oliva CR; Gillespie GY
    J Neurooncol; 2005 Sep; 74(2):123-33. PubMed ID: 16193382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit.
    Oliva CR; Zhang W; Langford C; Suto MJ; Griguer CE
    Oncotarget; 2017 Jun; 8(23):37568-37583. PubMed ID: 28455961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histochemical evaluation of energy metabolism in rat glioma.
    Ikezaki K; Black KL; Conklin SG; Becker DP
    Neurol Res; 1992 Sep; 14(4):289-93. PubMed ID: 1360622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opposing effects of 2-deoxy-d-glucose on interictal- and ictal-like activity when K
    Nedergaard S; Andreasen M
    J Neurophysiol; 2018 May; 119(5):1912-1923. PubMed ID: 29412775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential sensitivity to 2-deoxy-D-glucose between two pancreatic cell lines correlates with GLUT-1 expression.
    Maher JC; Savaraj N; Priebe W; Liu H; Lampidis TJ
    Pancreas; 2005 Mar; 30(2):e34-9. PubMed ID: 15714127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gliomas are driven by glycolysis: putative roles of hexokinase, oxidative phosphorylation and mitochondrial ultrastructure.
    Oudard S; Boitier E; Miccoli L; Rousset S; Dutrillaux B; Poupon MF
    Anticancer Res; 1997; 17(3C):1903-11. PubMed ID: 9216643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative phosphorylation activation is an important characteristic of DOX resistance in hepatocellular carcinoma cells.
    Wu L; Zhao J; Cao K; Liu X; Cai H; Wang J; Li W; Chen Z
    Cell Commun Signal; 2018 Feb; 16(1):6. PubMed ID: 29402287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of AMP-activated kinase modulates sensitivity of glioma cells against epidermal growth factor receptor inhibition.
    Hartel I; Ronellenfitsch M; Wanka C; Wolking S; Steinbach JP; Rieger J
    Int J Oncol; 2016 Jul; 49(1):173-80. PubMed ID: 27121290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carboxyamidotriazole inhibits oxidative phosphorylation in cancer cells and exerts synergistic anti-cancer effect with glycolysis inhibition.
    Ju R; Guo L; Li J; Zhu L; Yu X; Chen C; Chen W; Ye C; Zhang D
    Cancer Lett; 2016 Jan; 370(2):232-41. PubMed ID: 26522259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic state of glioma stem cells and nontumorigenic cells.
    Vlashi E; Lagadec C; Vergnes L; Matsutani T; Masui K; Poulou M; Popescu R; Della Donna L; Evers P; Dekmezian C; Reue K; Christofk H; Mischel PS; Pajonk F
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):16062-7. PubMed ID: 21900605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target.
    Lapa B; Gonçalves AC; Jorge J; Alves R; Pires AS; Abrantes AM; Coucelo M; Abrunhosa A; Botelho MF; Nascimento-Costa JM; Sarmento-Ribeiro AB
    Med Oncol; 2020 Jul; 37(8):72. PubMed ID: 32725458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.
    Castro BA; Flanigan P; Jahangiri A; Hoffman D; Chen W; Kuang R; De Lay M; Yagnik G; Wagner JR; Mascharak S; Sidorov M; Shrivastav S; Kohanbash G; Okada H; Aghi MK
    Oncogene; 2017 Jun; 36(26):3749-3759. PubMed ID: 28218903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spatially Resolved Bioenergetic and Genetic Reprogramming Through the Brain of Rats Bearing Implanted C6 Gliomas As Detected by Multinuclear High-Resolution Magic Angle Spinning and Genomic Analysis.
    Righi V; García-Martín ML; Mucci A; Schenetti L; Tugnoli V; Lopez-Larrubia P; Cerdán S
    J Proteome Res; 2018 Sep; 17(9):2953-2962. PubMed ID: 30129764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current evidence of temozolomide and bevacizumab in treatment of gliomas.
    Nanegrungsunk D; Onchan W; Chattipakorn N; Chattipakorn SC
    Neurol Res; 2015 Feb; 37(2):167-83. PubMed ID: 25033940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.
    Kessler T; Sahm F; Blaes J; Osswald M; Rübmann P; Milford D; Urban S; Jestaedt L; Heiland S; Bendszus M; Hertenstein A; Pfenning PN; Ruiz de Almodóvar C; Wick A; Winkler F; von Deimling A; Platten M; Wick W; Weiler M
    Oncotarget; 2015 Oct; 6(31):31050-68. PubMed ID: 25682871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Periostin (POSTN) Regulates Tumor Resistance to Antiangiogenic Therapy in Glioma Models.
    Park SY; Piao Y; Jeong KJ; Dong J; de Groot JF
    Mol Cancer Ther; 2016 Sep; 15(9):2187-97. PubMed ID: 27307601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model.
    Towner RA; Ihnat M; Saunders D; Bastian A; Smith N; Pavana RK; Gangjee A
    BMC Cancer; 2015 Jul; 15():522. PubMed ID: 26177924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12.
    Tabatabai G; Frank B; Möhle R; Weller M; Wick W
    Brain; 2006 Sep; 129(Pt 9):2426-35. PubMed ID: 16835250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.